Physical activity, physical fitness and the effect of exercise training interventions in lymphoma patients: a systematic review Nele VermaetePascal WolterRik Gosselink Review Article 14 February 2013 Pages: 1007 - 1021
Persisting fatigue in Hodgkin lymphoma survivors: a systematic review Laurien A. DaniëlsSimone OerlemansCarien L. Creutzberg Review Article 01 June 2013 Pages: 1023 - 1032
Rituximab, bendamustine, and lenalidomide in patients with aggressive B cell lymphoma not eligible for high-dose chemotherapy or anthracycline-based therapy: phase I results of the SAKK 38/08 trial F. HitzN. FischerOn behalf of Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland Original Article 17 April 2013 Pages: 1033 - 1040
DexaBEAM versus ICE salvage regimen prior to autologous transplantation for relapsed or refractory aggressive peripheral T cell lymphoma: a retrospective evaluation of parallel patient cohorts of one center Jan-Henrik MikeschMareike KuhlmannNils H. Thoennissen Original Article 27 March 2013 Pages: 1041 - 1048
High-dose imatinib versus high-dose imatinib in combination with intermediate-dose cytarabine in patients with first chronic phase myeloid leukemia: a randomized phase III trial of the Dutch-Belgian HOVON study group Noortje ThielenBronno van der HoltJan J. Cornelissen Original Article 10 April 2013 Pages: 1049 - 1056
Polymorphisms of the IL-23R gene are associated with primary immune thrombocytopenia but not with the clinical outcome of pulsed high-dose dexamethasone therapy Yanxia ZhanFanli HuaYunfeng Cheng Original Article 07 April 2013 Pages: 1057 - 1062
The clinical characteristics and prognostic significance of MN1 gene and MN1-associated microRNA expression in adult patients with de novo acute myeloid leukemia Lili XiangMan LiWeiying Gu Original Article 21 March 2013 Pages: 1063 - 1069
Impact of NOD2 polymorphisms on infectious complications following chemotherapy in patients with acute myeloid leukaemia Olaposi YomadeBärbel Spies-WeisshartSebastian Scholl Original Article 05 April 2013 Pages: 1071 - 1077
Monitoring dendritic cell and cytokine biomarkers during remission prior to relapse in patients with FLT3-ITD acute myeloid leukemia Mareike RickmannLaura MackeRenata Stripecke Original Article Open access 25 April 2013 Pages: 1079 - 1090
Homoharringtonine in combination with cytarabine and aclarubicin in the treatment of refractory/relapsed acute myeloid leukemia: a single-center experience Wenjuan YuLiping MaoJie Jin Original Article 18 April 2013 Pages: 1091 - 1100
Escalated daunorubicin dosing as an induction treatment for Philadelphia-negative adult acute lymphoblastic leukemia Sang Min LeeWon Sik LeeThe Korean Society of Hematology Adult ALL working party Original Article 05 April 2013 Pages: 1101 - 1110
Combined use of WT1 and flow cytometry monitoring can promote sensitivity of predicting relapse after allogeneic HSCT without affecting specificity Xiao-su ZhaoChen-hua YanXiao-jun Huang Original Article 17 May 2013 Pages: 1111 - 1119
Ferritin concentrations correlate to outcome of hematopoietic stem cell transplantation but do not serve as biomarker of graft-versus-host disease M. GroßekatthöferE. D. GüclüM. G. Seidel Original Article 19 April 2013 Pages: 1121 - 1128
Double-hit myeloma with IGH/MYC and IGH/CCND1 translocations Misuk JiSeongsoo JangEul-Ju Seo Letter to the Editor 10 January 2013 Pages: 1129 - 1131
Bevacizumab treatment followed by maintenance in life-threatening POEMS syndrome Vittorio PerfettiGiovanni PalladiniGiampaolo Merlini Letter to the Editor 19 January 2013 Pages: 1133 - 1134
Bortezomib induced a phrenic palsy in a multiple myeloma patient Vitalie NizeicaPhilippe ColletHubert Marotte Letter to the Editor 01 February 2013 Pages: 1135 - 1136
Maintenance therapy with dasatinib after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia Chieh-Lin Jerry TengJui-Ting YuWen-Li Hwang Letter to the Editor 11 January 2013 Pages: 1137 - 1139
Actinomycotic brain abscess as the first clinical manifestation of hereditary hemorrhagic telangiectasia—case report and review of the literature M. KoubaaD. LahianiM. Ben Jemâa Letter to the Editor 30 December 2012 Pages: 1141 - 1143
Profound thrombocytopenia in patient with ITP treated with chemotherapy for breast cancer and subsequent remission after romiplostim Ann ZimrinSaranya Chumsri Letter to the Editor 18 January 2013 Pages: 1145 - 1146
A common founder mutation p.P2063S in exon 36 of VWF in 11 unrelated Indian von Willebrand disease (VWD) families Priyanka KasatkarKanjaksha GhoshShrimati Shetty Letter to the Editor 27 January 2013 Pages: 1147 - 1148
Killing two birds with one stone: BRAF V600E inhibitor therapy for hairy cell leukemia and Langerhans/dendritic cell sarcoma Vivek SubbiahIshwaria Mohan Subbiah Letter to the Editor 16 January 2013 Pages: 1149 - 1149
